Cell Growth & Differentiation, Vol 8, Issue 8 829-838, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis

JM Jones, L Attardi, LA Godley, R Laucirica, D Medina, T Jacks, HE Varmus and LA Donehower
Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030, USA.

Loss or mutation of p53 may have multiple biological and genetic effects that result in accelerated tumor progression. Loss of p53 in some tumors has been correlated with a marked decrease in tumor cell apoptosis. p53 loss may also accelerate tumor growth through an increase in cell proliferation rates. To examine the effects of p53 loss on tumor progression in a controlled experimental context, we previously crossed p53-deficient mice to mammary tumor-susceptible Wnt-1 transgenic (TG) mice. The resulting female Wnt-1 TG offspring of this cross all developed mammary tumors, regardless of p53 status (p53+/+, p53+/-, or p53-/-). However, female p53-/- Wnt-1 TG mice developed tumors much sooner than their p53+/+ counterparts. In this report, we demonstrate that the average growth rates of tumors missing (p53-/-) or losing p53 (p53+/- with loss of heterozygosity) are accelerated compared to tumors with both wild-type p53 alleles (p53+/+). This accelerated growth rate appears to be due primarily to increases in rates of tumor cell proliferation. Tumor cell apoptotic levels were modest and were not measurably different in the presence or absence of wild-type p53. These results differ substantially from other mouse tumor models in which p53 loss was closely correlated with accelerated growth rates through attenuated apoptosis. Thus, the mechanisms by which p53 loss influences tumor progression may differ, depending on the tissue type and/or the oncogenic pathways involved.

This article has been cited by other articles:

				K. A. McAllister, C. D. Houle, J. Malphurs, T. Ward, N. K. Collins, W. Gersch, L. Wharey, J. C. Seely, L. Betz, L. M. Bennett, et al. Spontaneous and Irradiation-Induced Tumor Susceptibility in Brca2 Germline Mutant Mice and Cooperative Effects with a p53 Germline Mutation Toxicol Pathol, February 1, 2006; 34(2): 187 - 198. [Abstract] [Full Text] [PDF]

				J. S. L. Ho, W. Ma, D. Y. L. Mao, and S. Benchimol p53-Dependent Transcriptional Repression of c-myc Is Required for G1 Cell Cycle Arrest Mol. Cell. Biol., September 1, 2005; 25(17): 7423 - 7431. [Abstract] [Full Text] [PDF]

				S. D. Hursting, J. A. Lavigne, D. Berrigan, L. A. Donehower, B. J. Davis, J. M. Phang, J. C. Barrett, and S. N. Perkins Diet-Gene Interactions in p53-Deficient Mice: Insulin-like Growth Factor-1 as a Mechanistic Target J. Nutr., September 1, 2004; 134(9): 2482S - 2486S. [Abstract] [Full Text] [PDF]

				L. Y. Y. Fong, H. Ishii, V. T. Nguyen, A. Vecchione, J. L. Farber, C. M. Croce, and K. Huebner p53 Deficiency Accelerates Induction and Progression of Esophageal and Forestomach Tumors in Zinc-deficient Mice Cancer Res., January 1, 2003; 63(1): 186 - 195. [Abstract] [Full Text] [PDF]

				C. A. Vaslet, N. J. Messier, and A. B. Kane Accelerated Progression of Asbestos-Induced Mesotheliomas in Heterozygous p53+/- Mice Toxicol. Sci., August 1, 2002; 68(2): 331 - 338. [Abstract] [Full Text] [PDF]

				S. D. Hursting, S. N. Perkins, J. M. Phang, and J. C. Barrett Diet and Cancer Prevention Studies in p53-Deficient Mice J. Nutr., November 1, 2001; 131(11): 3092S - 3094. [Abstract] [Full Text] [PDF]

				T. Portis, W. J. Grossman, J. C. Harding, J. L. Hess, and L. Ratner Analysis of p53 Inactivation in a Human T-Cell Leukemia Virus Type 1 Tax Transgenic Mouse Model J. Virol., March 1, 2001; 75(5): 2185 - 2193. [Abstract] [Full Text]

				S. D. Hursting, S. N. Perkins, L. A. Donehower, and B. J. Davis Cancer Prevention Studies in p53-Deficient Mice Toxicol Pathol, January 1, 2001; 29(1): 137 - 141. [Abstract] [PDF]

				I. Unnikrishnan, A. Radfar, J. Jenab-Wolcott, and N. Rosenberg p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells Mol. Cell. Biol., July 1, 1999; 19(7): 4825 - 4831. [Abstract] [Full Text] [PDF]

				J. M. Jones, X.-S. Cui, D. Medina, and L. A. Donehower Heterozygosity of p21WAF1/CIP1 Enhances Tumor Cell Proliferation and Cyclin D1-associated Kinase Activity in a Murine Mammary Cancer Model Cell Growth Differ., April 1, 1999; 10(4): 213 - 222. [Abstract] [Full Text]